Definium Therapeutics, Inc. (DFTX) Insider Trading

Name: Definium Therapeutics, Inc. (DFTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 29, 2026): Karlin Daniel (Chief Medical Officer): Sale of 10,853 shares, $396.9K.

Get alerted when insiders trade DFTX

Email address

Loading company data...

Loading company details...